Leqvio (Inclisiran) Monitoring for Adults Aged 30, 49: Lab Schedules, Safety Checks, and Follow-Up
Evidence-based monitoring guide for inclisiran (Leqvio) in adults aged 30 to 49, covering lipid panels, liver function tests, injection-site checks, and long-term follow-up schedules.

